US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 7.910
  • +0.560+7.62%
Close May 14 16:00 ET
  • 8.060
  • +0.150+1.90%
Post 18:11 ET
491.64MMarket Cap-4913P/E (TTM)

Fulcrum Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
-9.09%-24.12M
-23.67%-97.05M
9.89%-19.7M
-23.52%-27.88M
-53.56%-27.37M
Net income from continuing operations
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
-14.59%-23.74M
-73.40%-34.07M
Depreciation and amortization
-15.37%479K
-10.02%2.17M
-14.04%508K
-13.09%531K
-16.12%567K
5.60%566K
-4.02%2.41M
-4.83%591K
-1.29%611K
0.60%676K
Change In working capital
40.93%-1.65M
-49.10%-4.61M
-132.43%-1.03M
80.88%-1.57M
-72.74%780K
-205.25%-2.79M
73.98%-3.09M
200.16%3.18M
-57.29%-8.22M
289.22%2.86M
-Change in receivables
313.08%537K
-109.04%-308K
-92.51%43K
-74.41%76K
-86.91%-557K
-95.41%130K
408.14%3.41M
123.25%574K
158.12%297K
-138.40%-298K
-Change in prepaid assets
253.83%803K
-530.59%-1.07M
-181.20%-622K
27.99%-692K
1,176.06%764K
-643.75%-522K
-26.87%-170K
75.69%766K
58.98%-961K
-123.13%-71K
-Change in payables and accrued expense
-33.63%-2.82M
-170.21%-1.68M
-96.27%92K
91.53%-593K
-83.92%934K
-11.81%-2.11M
-121.25%-621K
546.98%2.47M
-559.95%-7.01M
174.56%5.81M
-Change in other current assets
-68.92%23K
106.02%94K
-250.00%-21K
-28.57%5K
102.79%36K
127.01%74K
-4,438.89%-1.56M
73.91%-6K
-41.67%7K
-4,128.13%-1.29M
-Change in other working capital
47.37%-190K
60.26%-1.65M
15.65%-523K
34.05%-368K
69.18%-397K
78.55%-361K
69.51%-4.15M
58.64%-620K
85.72%-558K
66.47%-1.29M
Cash from discontinued investing activities
Operating cash flow
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
-9.09%-24.12M
-23.67%-97.05M
9.89%-19.7M
-23.52%-27.88M
-53.56%-27.37M
Investing cash flow
Cash flow from continuing investing activities
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
-577.85%-93.94M
109.57%12.41M
-299.85%-36.36M
97.86%-2.28M
219.13%31.4M
Net PPE purchase and sale
83.63%-28K
74.12%-508K
33.62%-77K
77.03%-65K
85.20%-195K
30.49%-171K
-14.59%-1.96M
77.65%-116K
22.89%-283K
-133.27%-1.32M
Net investment purchase and sale
140.69%38.16M
-351.70%-36.18M
150.85%18.43M
1,056.16%19.09M
-38.65%20.07M
-571.09%-93.77M
111.24%14.38M
-322.69%-36.25M
98.12%-2M
226.85%32.71M
Cash from discontinued investing activities
Investing cash flow
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
-577.85%-93.94M
109.57%12.41M
-299.85%-36.36M
97.86%-2.28M
219.13%31.4M
Financing cash flow
Cash flow from continuing financing activities
-98.60%1.65M
40.08%118.12M
31.65%287K
0
-94.95%142K
33,719.83%117.69M
-54.79%84.32M
-75.53%218K
-41.30%80.95M
1,244.98%2.81M
Net common stock issuance
--0
45.22%117.35M
--0
--0
--0
--117.35M
-55.81%80.8M
36.36%-49K
-40.34%80.85M
--0
Proceeds from stock option exercised by employees
374.43%1.65M
-77.92%777K
7.49%287K
--0
-94.95%142K
0.00%348K
-4.06%3.52M
-72.45%267K
-96.08%93K
1,116.88%2.81M
Cash from discontinued financing activities
Financing cash flow
-98.60%1.65M
40.08%118.12M
31.65%287K
--0
-94.95%142K
33,719.83%117.69M
-54.79%84.32M
-75.53%218K
-41.30%80.95M
1,244.98%2.81M
Net cash flow
Beginning cash position
-26.35%26.66M
-0.86%36.19M
-66.13%31.17M
-15.00%35.06M
4.13%35.83M
-0.86%36.19M
-37.22%36.5M
38.26%92.03M
-28.73%41.25M
-66.22%34.41M
Current changes in cash
4,082.14%14.5M
-2,936.62%-9.54M
91.91%-4.52M
-107.65%-3.89M
-111.23%-768K
82.66%-364K
98.55%-314K
-85.76%-55.84M
484.14%50.79M
115.56%6.84M
End cash Position
14.86%41.15M
-26.35%26.66M
-26.35%26.66M
-66.13%31.17M
-15.00%35.06M
4.13%35.83M
-0.86%36.19M
-0.86%36.19M
38.26%92.03M
-28.73%41.25M
Free cash flow
-4.22%-25.31M
7.62%-91.47M
-17.28%-23.24M
18.44%-22.97M
26.86%-20.98M
-8.66%-24.29M
-23.47%-99.01M
11.46%-19.81M
-22.78%-28.17M
-56.01%-28.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.84%-25.28M6.27%-90.97M-17.58%-23.16M17.85%-22.91M24.05%-20.79M-9.09%-24.12M-23.67%-97.05M9.89%-19.7M-23.52%-27.88M-53.56%-27.37M
Net income from continuing operations -8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M-14.59%-23.74M-73.40%-34.07M
Depreciation and amortization -15.37%479K-10.02%2.17M-14.04%508K-13.09%531K-16.12%567K5.60%566K-4.02%2.41M-4.83%591K-1.29%611K0.60%676K
Change In working capital 40.93%-1.65M-49.10%-4.61M-132.43%-1.03M80.88%-1.57M-72.74%780K-205.25%-2.79M73.98%-3.09M200.16%3.18M-57.29%-8.22M289.22%2.86M
-Change in receivables 313.08%537K-109.04%-308K-92.51%43K-74.41%76K-86.91%-557K-95.41%130K408.14%3.41M123.25%574K158.12%297K-138.40%-298K
-Change in prepaid assets 253.83%803K-530.59%-1.07M-181.20%-622K27.99%-692K1,176.06%764K-643.75%-522K-26.87%-170K75.69%766K58.98%-961K-123.13%-71K
-Change in payables and accrued expense -33.63%-2.82M-170.21%-1.68M-96.27%92K91.53%-593K-83.92%934K-11.81%-2.11M-121.25%-621K546.98%2.47M-559.95%-7.01M174.56%5.81M
-Change in other current assets -68.92%23K106.02%94K-250.00%-21K-28.57%5K102.79%36K127.01%74K-4,438.89%-1.56M73.91%-6K-41.67%7K-4,128.13%-1.29M
-Change in other working capital 47.37%-190K60.26%-1.65M15.65%-523K34.05%-368K69.18%-397K78.55%-361K69.51%-4.15M58.64%-620K85.72%-558K66.47%-1.29M
Cash from discontinued investing activities
Operating cash flow -4.84%-25.28M6.27%-90.97M-17.58%-23.16M17.85%-22.91M24.05%-20.79M-9.09%-24.12M-23.67%-97.05M9.89%-19.7M-23.52%-27.88M-53.56%-27.37M
Investing cash flow
Cash flow from continuing investing activities 140.59%38.13M-395.59%-36.69M150.48%18.35M934.58%19.02M-36.69%19.88M-577.85%-93.94M109.57%12.41M-299.85%-36.36M97.86%-2.28M219.13%31.4M
Net PPE purchase and sale 83.63%-28K74.12%-508K33.62%-77K77.03%-65K85.20%-195K30.49%-171K-14.59%-1.96M77.65%-116K22.89%-283K-133.27%-1.32M
Net investment purchase and sale 140.69%38.16M-351.70%-36.18M150.85%18.43M1,056.16%19.09M-38.65%20.07M-571.09%-93.77M111.24%14.38M-322.69%-36.25M98.12%-2M226.85%32.71M
Cash from discontinued investing activities
Investing cash flow 140.59%38.13M-395.59%-36.69M150.48%18.35M934.58%19.02M-36.69%19.88M-577.85%-93.94M109.57%12.41M-299.85%-36.36M97.86%-2.28M219.13%31.4M
Financing cash flow
Cash flow from continuing financing activities -98.60%1.65M40.08%118.12M31.65%287K0-94.95%142K33,719.83%117.69M-54.79%84.32M-75.53%218K-41.30%80.95M1,244.98%2.81M
Net common stock issuance --045.22%117.35M--0--0--0--117.35M-55.81%80.8M36.36%-49K-40.34%80.85M--0
Proceeds from stock option exercised by employees 374.43%1.65M-77.92%777K7.49%287K--0-94.95%142K0.00%348K-4.06%3.52M-72.45%267K-96.08%93K1,116.88%2.81M
Cash from discontinued financing activities
Financing cash flow -98.60%1.65M40.08%118.12M31.65%287K--0-94.95%142K33,719.83%117.69M-54.79%84.32M-75.53%218K-41.30%80.95M1,244.98%2.81M
Net cash flow
Beginning cash position -26.35%26.66M-0.86%36.19M-66.13%31.17M-15.00%35.06M4.13%35.83M-0.86%36.19M-37.22%36.5M38.26%92.03M-28.73%41.25M-66.22%34.41M
Current changes in cash 4,082.14%14.5M-2,936.62%-9.54M91.91%-4.52M-107.65%-3.89M-111.23%-768K82.66%-364K98.55%-314K-85.76%-55.84M484.14%50.79M115.56%6.84M
End cash Position 14.86%41.15M-26.35%26.66M-26.35%26.66M-66.13%31.17M-15.00%35.06M4.13%35.83M-0.86%36.19M-0.86%36.19M38.26%92.03M-28.73%41.25M
Free cash flow -4.22%-25.31M7.62%-91.47M-17.28%-23.24M18.44%-22.97M26.86%-20.98M-8.66%-24.29M-23.47%-99.01M11.46%-19.81M-22.78%-28.17M-56.01%-28.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg